Vertex's Reshma Kewalramani takes CEO post as longtime vet Jeff Leiden moves to new role
Close to 8 years after taking the helm at Vertex, Jeff Leiden is handing the CEO job to current CMO Reshma Kewalramani and moving to the executive chairman’s role.
One of the best-known biopharma execs in the Boston hub, Leiden is leaving at the top of his game — though his rep has been dinged somewhat by a rough-and-tumble series of negotiations with single payers in Europe.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 83,100+ biopharma pros reading Endpoints daily — and it's free.